Stocks in play: Bee Vectoring Technologies International Inc
Announces significant Research and Development advancements for its proprietary biological control agent Clonostachys rosea strain CR-7 (CR-7) use as a seed treatment solution for soybeans. This breakthrough underscores the product’s compatibility and safety on seeds, propelling it toward commercialization in the agriculture sector. Bee Vectoring Technologies International Inc shares C.BEE are trading unchanged at $0.02.
Read:
Lithium's Future Looks Bright: Demand Expected to Surge by 1,500% by 2050 According to IEA Data
Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer
Data Center Infrastructure Management Market on Track for Rapid Growth
Tech Firms Innovate Amidst AI Boom, Eyeing $266 Billion Generative Market